Ming Xia1, Chi Zhang1, Jian Gu1, Jing Chen2, Lin-Chi Wang3, Yan Lu3, Chun-Yan Huang3, Yong-Ming He1, Xiang-Jun Yang4. 1. Division of Cardiology, The First Affiliated Hospital of Soochow University, PR China. 2. Division of Geriatrics, The First Affiliated Hospital of Soochow University, PR China. 3. Suzhou Center for Disease Control and Prevention, PR China. 4. Division of Cardiology, The First Affiliated Hospital of Soochow University, PR China. Electronic address: xiangjun_yang218@163.com.
Abstract
BACKGROUND: Little is known about the relationship between C-reactive protein (CRP) and long-term mortality after acute myocardial infarction (AMI) in diabetic patients. The current study aimed to examine whether CRP levels are associated with for long-term all-cause, cardiovascular, and cardiac mortality in AMI patients with diabetes and those without separately. METHODS: The cohort study included 663 diabetic and 1853 non-diabetic patients with AMI. The median follow-up time was 1045 days (2.9 years). RESULTS: According to the median concentration of serum CRP (8.95 mg/l), the patients were divided into two groups. The low CRP level group (<8.95 mg/l) served as a reference. In diabetic patients with AMI, the adjusted hazard ratios (HRs) for long-term all-cause, cardiovascular, and cardiac mortality were 1.62 (P = 0.027), 1.91 (P = 0.008), and 2.08 (P = 0.007), respectively. In non-diabetic patients with AMI, the adjusted hazard ratios (HRs) for long-term all-cause, cardiovascular, and cardiac mortality were 1.72 (P < 0.001), 1.8 (P < 0.001), and 1.78 (P = 0.001), respectively. CONCLUSIONS: Regardless of whether patients had diabetes or not, CRP value is an independent predictor of long-term, all-cause, cardiovascular, and cardiac mortality after AMI.
BACKGROUND: Little is known about the relationship between C-reactive protein (CRP) and long-term mortality after acute myocardial infarction (AMI) in diabeticpatients. The current study aimed to examine whether CRP levels are associated with for long-term all-cause, cardiovascular, and cardiac mortality in AMI patients with diabetes and those without separately. METHODS: The cohort study included 663 diabetic and 1853 non-diabeticpatients with AMI. The median follow-up time was 1045 days (2.9 years). RESULTS: According to the median concentration of serum CRP (8.95 mg/l), the patients were divided into two groups. The low CRP level group (<8.95 mg/l) served as a reference. In diabeticpatients with AMI, the adjusted hazard ratios (HRs) for long-term all-cause, cardiovascular, and cardiac mortality were 1.62 (P = 0.027), 1.91 (P = 0.008), and 2.08 (P = 0.007), respectively. In non-diabeticpatients with AMI, the adjusted hazard ratios (HRs) for long-term all-cause, cardiovascular, and cardiac mortality were 1.72 (P < 0.001), 1.8 (P < 0.001), and 1.78 (P = 0.001), respectively. CONCLUSIONS: Regardless of whether patients had diabetes or not, CRP value is an independent predictor of long-term, all-cause, cardiovascular, and cardiac mortality after AMI.
Authors: Xiao Long Lin; Hao Xuan Sun; Fan Qi Li; Jin Yang Zhao; Dong Hui Zhao; Jing Hua Liu; Qian Fan Journal: Clin Cardiol Date: 2022-01-23 Impact factor: 2.882